SciDev Limited (INFA) - Net Assets
Based on the latest financial reports, SciDev Limited (INFA) has net assets worth €50.05 Million EUR (≈ $58.51 Million USD) as of June 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€75.23 Million ≈ $87.95 Million USD) and total liabilities (€25.18 Million ≈ $29.43 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Read SciDev Limited (INFA) financial obligations for a breakdown of total debt and financial obligations.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €50.05 Million |
| % of Total Assets | 66.53% |
| Annual Growth Rate | 45.72% |
| 5-Year Change | 58.31% |
| 10-Year Change | N/A |
| Growth Volatility | 84.4 |
SciDev Limited - Net Assets Trend (2017–2025)
This chart illustrates how SciDev Limited's net assets have evolved over time, based on quarterly financial data. Also explore INFA asset base for the complete picture of this company's asset base.
Annual Net Assets for SciDev Limited (2017–2025)
The table below shows the annual net assets of SciDev Limited from 2017 to 2025. For live valuation and market cap data, see INFA market cap overview.
| Year | Net Assets | Change |
|---|---|---|
| 2025-06-30 | €50.05 Million ≈ $58.51 Million |
-0.37% |
| 2024-06-30 | €50.24 Million ≈ $58.73 Million |
+4.61% |
| 2023-06-30 | €48.02 Million ≈ $56.15 Million |
-1.66% |
| 2022-06-30 | €48.84 Million ≈ $57.10 Million |
+54.48% |
| 2021-06-30 | €31.61 Million ≈ $36.96 Million |
+81.60% |
| 2020-06-30 | €17.41 Million ≈ $20.35 Million |
+270.49% |
| 2019-06-30 | €4.70 Million ≈ $5.49 Million |
+18.95% |
| 2018-06-30 | €3.95 Million ≈ $4.62 Million |
+60.47% |
| 2017-06-30 | €2.46 Million ≈ $2.88 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to SciDev Limited's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 400781300.0% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (June 2025)
| Component | Amount | Percentage |
|---|---|---|
| Other Components | €119.42 Million | 238.61% |
| Total Equity | €50.05 Million | 100.00% |
SciDev Limited Competitors by Market Cap
The table below lists competitors of SciDev Limited ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Aksara Global Development Tbk PT
JK:GAMA
|
$10.56 Million |
|
Loyal Textile Mills Limited
NSE:LOYALTEX
|
$10.57 Million |
|
REC Silicon ASA
OL:RECSI
|
$10.58 Million |
|
OFAL
NASDAQ:OFAL
|
$10.58 Million |
|
Intelicare Holdings Ltd
AU:ICR
|
$10.55 Million |
|
NEWMARK SECURITY LS-005
F:NN10
|
$10.54 Million |
|
Reliance Home Finance Limited
NSE:RHFL
|
$10.54 Million |
|
HYDROGEN UTOPIA INT.-001
F:D60
|
$10.54 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in SciDev Limited's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 50,237,000 to 50,050,000, a change of -187,000 (-0.4%).
- Net loss of 878,000 reduced equity.
- Other factors increased equity by 691,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | €-878.00K | -1.75% |
| Other Changes | €691.00K | +1.38% |
| Total Change | €- | -0.37% |
Book Value vs Market Value Analysis
This analysis compares SciDev Limited's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.18x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
- The price-to-book ratio has decreased from 1.03x to 0.18x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2017-06-30 | €0.05 | €0.05 | x |
| 2018-06-30 | €0.06 | €0.05 | x |
| 2019-06-30 | €0.04 | €0.05 | x |
| 2020-06-30 | €0.12 | €0.05 | x |
| 2021-06-30 | €0.20 | €0.05 | x |
| 2022-06-30 | €0.26 | €0.05 | x |
| 2023-06-30 | €0.25 | €0.05 | x |
| 2024-06-30 | €0.26 | €0.05 | x |
| 2025-06-30 | €0.26 | €0.05 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently SciDev Limited utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -1.75%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -0.85%
- • Asset Turnover: 1.37x
- • Equity Multiplier: 1.50x
- Recent ROE (-1.75%) is above the historical average (-4.34%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2017 | -27.71% | -36.93% | 0.60x | 1.25x | €-928.32K |
| 2018 | 25.36% | 49.37% | 0.44x | 1.16x | €606.83K |
| 2019 | -43.25% | -76.53% | 0.45x | 1.26x | €-2.50 Million |
| 2020 | -5.03% | -4.89% | 0.66x | 1.56x | €-2.62 Million |
| 2021 | 10.92% | 8.12% | 0.76x | 1.78x | €291.51K |
| 2022 | -1.26% | -1.11% | 0.78x | 1.46x | €-5.50 Million |
| 2023 | -0.71% | -0.38% | 1.33x | 1.40x | €-5.14 Million |
| 2024 | 4.33% | 1.99% | 1.51x | 1.43x | €-2.85 Million |
| 2025 | -1.75% | -0.85% | 1.37x | 1.50x | €-5.88 Million |
Industry Comparison
This section compares SciDev Limited's net assets metrics with peer companies in the Specialty Chemicals industry.
Industry Context
- Industry: Specialty Chemicals
- Average net assets among peers: $3,071,504,005
- Average return on equity (ROE) among peers: -30.08%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| SciDev Limited (INFA) | €50.05 Million | -27.71% | 0.50x | $10.56 Million |
| GRAPHENE MANUFACT.GROUP (0GF) | $10.10 Million | -116.54% | 0.65x | $152.93 Million |
| Orion Engineered Carbons SA (0OE) | $478.50 Million | 21.63% | 2.83x | $318.41 Million |
| H&R GmbH & Co. KGaA (2HRA) | $189.16 Million | -7.42% | 2.14x | $183.88 Million |
| Dotz Nano Ltd (57N) | $3.79 Million | -160.22% | 0.25x | $3.81 Million |
| EXPLOS. PROD. CHIM.EO 31 (9Z50) | $106.13 Million | 5.52% | 2.43x | $536.15 Million |
| Altech Chemicals Ltd (A3Y) | $20.44 Million | -57.36% | 0.80x | $27.76 Million |
| AlzChem Group AG (ACT) | $0.00 | 0.00% | 0.00x | $1.83 Billion |
| AIR LIQUIDE ADR 1/5/EO 11 (AILA) | $25.04 Billion | 12.29% | 0.93x | $103.86 Billion |
| AKZO NOBEL SPONS.ADRS 1/3 (AKUP) | $4.82 Billion | 13.17% | 1.89x | $8.57 Billion |
| BRAIN Biotech AG (BNN) | $41.83 Million | -11.89% | 0.86x | $51.56 Million |
About SciDev Limited
SciDev Limited engages in the provision of environmental solutions focused on water intensive industries in Australia, the United States, Asia, and internationally. The company operates in two segments, Chemical Services and Water Technologies. It develops, manufactures, and supplies proprietary chemicals, including natural and synthetic polymers for flocculation, filtration, sludge dewatering, f… Read more